Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Managing a packet service call within mobile communications user equipment
Method and an apparatus for processing an audio signal
Semiconductor chip, stack module, and memory card
Determination method for a reinitialization of a temporal sequence of fluoroscopic images of an examination region of an examination object
Semiconductor device element formed on SOI substrate comprising a hollow region, and having capacitors in an electric field alleviation region
Lubricant composition and antioxident composition
  Randomly Featured Patents
Revolver valve for discharging a pressurized vessel in a fiber stock preparation system
Handle device for use on trunk lids of automobiles
Device with shutter and element for the reinsertion of a shutter into a guide slide
Chair component
Apparatus and method for reducing power consumption in a mobile unit
Electrolytic process for the preparation of organic compounds
Cushioned sock
Drive arrangement for an instrument landing system glidepath antenna
Boil cooling method, boil cooling apparatus, flow channel structure, and applied technology field thereof
Optical fiber taps